Areas of Focus
- 心肌重构
- 心力衰竭的防治
Work Experience
- 2007.08-2011.01 武汉大学人民医院心血管内科主治医师、讲师
- 2011.01-2012.01 武汉大学人民医院心血管内科副主任医师、讲师
- 2012.01-2016.12 武汉大学人民医院心血管内科副教授、副主任医师
- 2016.12-至今 武汉大学人民医院心血管内科主任医师、副教授,院长助理
Academic Background & Achievements
- 1995-2006 武汉大学临床医学学士
- 2001-2004 武汉大学生物医学工程硕士
- 2004-2007 武汉大学内科学博士
- 获得2项国家自然科学基金资助
Publications
- Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury, Li N, Wang W, Zhou H, Wu Q, Duan M, Liu C, Wu H, Deng W, Shen D, Tang Q, 2020
- Geniposide protects against sepsis-induced myocardial dysfunction through AMPKα-dependent pathway, Song P, Shen DF, Meng YY, Kong CY, Zhang X, Yuan YP, Yan L, Tang QZ, Ma ZG, 2020
- Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling, Yuan Y, Wang J, Chen Q, Wu Q, Deng W, Zhou H, Shen DF, 2019
- Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats, Che Y, Shen DF, Wang ZP, Jin YG, Wu QQ, Wang SS, Yuan Y, 2019
- Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy, Wang ZP, Shen DF, Che Y, Jin YG, Wang SS, Wu QQ, Zhou H, Meng YY, Yuan Y, 2019
- The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction, Wang J, He W, Guo L, Zhang Y, Li H, Han SX, Shen DF, 2017
- The mechanism of TGF-beta/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells, Wang J, He W, Xu X, Guo L, Zhang Y, Han SX, Shen DF, 2017
- Shensongyangxin protects against pressure overload induced cardiac hypertrophy, Shen DF, Wu QQ, Ni J, Deng W, Wei C, Jia ZH, Zhou H, Zhou MQ, Bian ZY, Tang QZ, 2016
- Shensongyangxin protects cardiomyocytes against LPS-induced injury through the NF kappa B pathway, Shen DF, Ni J, Wu QQ, Deng W, Wei C, Jia ZH, Zhou H, Zhou MQ, Bian ZY, Tang QZ
Awards
- 2019年湖北省科技进步一等奖《心力衰竭的结构重构及其防治》
- 2013年湖北省科技进步一等奖《心肌重构的发病基础与临床防治》